This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: ETH Zurich. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Antoine Florent Herzog: Innovator in Bioconjugates
Introduction
Antoine Florent Herzog is a notable inventor based in Zürich, Switzerland. He has made significant contributions to the field of bioconjugates, particularly in the context of cancer therapy. His innovative work focuses on the integration of antibodies with functionalized magnetic nanoparticles.
Latest Patents
Herzog holds a patent for "Bioconjugates of antibodies and functionalized magnetic nanoparticles." This invention relates to antibodies that are useful in both therapy and diagnosis. Specifically, it discloses bioconjugates that comprise one or more antibodies bound to functionalized, magnetic nanoparticles. These bioconjugates are particularly beneficial in cancer therapy, especially for the removal of circulating tumor cells. The patent also covers specific functionalized magnetic nanoparticles and the manufacturing processes for these bioconjugates.
Career Highlights
Antoine Florent Herzog is affiliated with the University of Zürich and ETH Zurich, where he continues to advance research in his field. His work has garnered attention for its potential applications in medical therapies.
Collaborations
Herzog has collaborated with notable colleagues such as Wendelin Jan Stark and Martin Zeltner, contributing to the advancement of research in bioconjugates and their applications.
Conclusion
Antoine Florent Herzog's innovative work in bioconjugates represents a significant advancement in cancer therapy. His contributions to the field highlight the importance of integrating technology with medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile